Open AccessVaccination of BALB/c mice with Leishmania donovani derived lipophosphoglycan does not conver cross-protection to L. major infections
Author(s) -
Willy K. Tonui
Publication year - 2004
Publication title -
east african medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.102
H-Index - 40
ISSN - 0012-835X
DOI - 10.4314/eamj.v80i5.8697
Subject(s) - lipophosphoglycan , leishmania donovani , vaccination , mycobacterium bovis , immunology , leishmania , virulence , microbiology and biotechnology , virology , biology , medicine , leishmaniasis , tuberculosis , mycobacterium tuberculosis , visceral leishmaniasis , parasite hosting , biochemistry , pathology , world wide web , computer science , gene
To determine whether Leishmania donovani-derived lipophosphoglycan (LPG) can confer cross-protection to L. major in susceptible BALB/c mice model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom